Patient Barriers to Participation in Breast Cancer Clinical Trials
Open Access
- 3 March 2020
- journal article
- editorial
- Published by Taylor & Francis in Breast Cancer Management
- Vol. 9 (1)
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Impact of broadening clinical trial eligibility criteria for advanced non-small cell lung cancer patients: Real-world analysis.Journal of Clinical Oncology, 2019
- Digital Medicine: A Primer on MeasurementDigital Biomarkers, 2019
- Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial ParticipationJNCI: Journal of the National Cancer Institute, 2019
- Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research Brain Metastases Working GroupJournal of Clinical Oncology, 2017
- Modernizing Clinical Trial Eligibility: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research Minimum Age Working GroupJournal of Clinical Oncology, 2017
- Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research StatementJournal of Clinical Oncology, 2017
- Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research Organ Dysfunction, Prior or Concurrent Malignancy, and Comorbidities Working GroupJournal of Clinical Oncology, 2017
- Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research HIV Working GroupJournal of Clinical Oncology, 2017